Gillette India Ltd.
GILLETTE · NSE · Consumer Defensive
₹7,722.5
-3.50 (-0.05%)
Our verdict
Hold51/100
Quality89
Valuation29
Momentum20
Financial trend56
Intrinsic value
Our fair value
₹6,067.9
Overvalued by 21%
Price ₹7,722.5Range ₹4,959.17–₹7,176.62
With a 20% margin of safety, our buy-below price is ₹4,854.32.
A
Financial health 100/100
Altman Z 19.34 · Safe zone
Piotroski F-score 4/9 — quality of earnings & balance sheet.
Investability checklist
Passed 7 of 13 checks54/100
- ✓ROE above 15%66.4%
- ✓Low debt (D/E < 0.5)0.00x
- ✓Positive free cash flow
- ✕Revenue growth > 10%3%
- ✓Earnings growing21%
- ✓Net margin ≥ 10%21.1%
- ✓Current ratio > 1.51.54
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 19.34
- ✕Piotroski ≥ 74/9
1-year price
EOD · 2026-06-151W
+1.3%
1M
-1.1%
3M
-3.4%
6M
-4.0%
1Y
—
Our scores
Durability89
Valuation43
Momentum20
Key fundamentals
Market cap
₹25,164 Cr
P/E ratio
47.1
P/B ratio
26.59
EPS (TTM)
₹163.79
ROE
66.4%
Debt / Equity
0.00x
Profit margin
21.1%
Free cash flow
₹486 Cr
52-week high
₹10,978.86
-29.66% from high
52-week low
₹7,253.5
Dividend yield
2.3%
Beta
0.24
SWOT snapshot
Strengths
- •Strong return on equity (66.4%).
- •Lightly leveraged balance sheet.
- •Healthy profit margin (21.1%).
- •Financially solid — Altman Z 19.34.
Weaknesses
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Earnings growing (21% YoY).
Threats
- •Trades ~21% above our estimated fair value.
About Gillette India Ltd.
Gillette India Limited engages in the manufacture and sale of grooming and oral care products in India and internationally. It offers shaving system and cartridges, blades, toiletries, razors, and other components. The company also offers toothbrushes and oral care products
More in Fast Moving Consumer Goods
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.